Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

ClinicalTrials.gov ID: NCT03834220

Public ClinicalTrials.gov record NCT03834220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Basket Study of the Oral Selective Pan-FGFR Inhibitor Debio 1347 in Subjects With Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the efficacy of Debio 1347 in terms of objective response rate (ORR) in participants with solid tumors harboring fibroblast growth factor receptor (FGFR)1-3 gene fusion/rearrangement.

Study identification

NCT ID
NCT03834220
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Debiopharm International SA
Industry
Enrollment
63 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2019 (Actual)
Primary completion
Dec 31, 2020 (Actual)
Completion
Jan 4, 2022 (Actual)
Last update posted
Feb 7, 2024

2019 – 2022

United States locations

U.S. sites
25
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Ironwood Cancer & Research Centers - Scottsdale Scottsdale Arizona 85260 —
University of Arizona Cancer Center Tucson Arizona 85721 —
Moores UCSD Cancer Center La Jolla California 92093 —
University of California San Francisco San Francisco California 94115 —
Sarcoma Oncology Center Santa Monica California 90403 —
H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa Florida 33612 —
James Graham Brown Cancer Center Louisville Kentucky 10202 —
Tulane University Cancer Center New Orleans Louisiana 70122 —
The John Hopkins Hospital Baltimore Maryland 21231 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
University of Michigan Ann Arbor Michigan 48109 —
Memorial Sloan Kettering Cancer Center Middletown New Jersey 07748 —
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
Memorial Sloan Kettering Cancer Center Harrison New York 10604 —
Memorial Sloan-Kettering Hospital New York New York 10065 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
UC Health, LLC. Cincinnati Ohio 45229 —
The Ohio State University Wexner Medical Center - James Cancer Hospital Columbus Ohio 43210 —
CTCA Cancer Treatment Centers Tulsa Oklahoma 74133 —
West Penn - Allegheny Oncology Network Pittsburgh Pennsylvania 15224 —
MD Anderson Cancer Center Houston Texas 77030 —
University of Utah Hospitals & Clinics Salt Lake City Utah 84108 —
Fred Hutchinson/Seattle Care Alliance Seattle Washington 98109 —
University of Wisconsin Madison Wisconsin 53706 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03834220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2024 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03834220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →